drugset / Trial / NCT00679653

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

NCT00679653 ↗

Phase 3 Completed 171 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of sibutramine treatment on weight reduction and blood pressure improvement in three groups with antihypertensive therapy whose blood pressure was not adequately controlled with antihypertensive combination treatment.

Timeline

Start
2002-02
Primary completion
2003-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sibutramine Small molecule 10 mg —
Comparator Sibutramine Small molecule 15 mg —
Comparator Felodipine Small molecule — —
Background HCT Unknown — —
Comparator Metoprolol Other / unclassified — —
Comparator Ramipril Small molecule — —
Comparator Verapamil Other / unclassified — —
Comparator trandolapril Small molecule — —